Characterization of the EZH2-MMSET Histone Methyltransferase Regulatory Axis in Cancer

Albert, 2010, Histone methyltransferases in cancer, Semin. Cell Dev. Biol., 21, 209, 10.1016/j.semcdb.2009.10.007 Bachmann, 2006, EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast, J. Clin. Oncol., 24, 268, 10.1200/JCO.2005.01.5180 Baylin, 2011, A decade of exploring the cancer epigenome - biological and translational implications, Nat. Rev. Cancer, 11, 726, 10.1038/nrc3130 Berezovska, 2006, Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer, Cell Cycle, 5, 1886, 10.4161/cc.5.16.3222 Bracken, 2007, The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells, Genes Dev., 21, 525, 10.1101/gad.415507 Brito, 2009, MMSET deregulation affects cell cycle progression and adhesion regulons in t(4;14) myeloma plasma cells, Haematologica, 94, 78, 10.3324/haematol.13426 Cao, 2002, Role of histone H3 lysine 27 methylation in Polycomb-group silencing, Science, 298, 1039, 10.1126/science.1076997 Cao, 2008, Repression of E-cadherin by the polycomb group protein EZH2 in cancer, Oncogene, 27, 7274, 10.1038/onc.2008.333 Cao, 2011, Coordinated regulation of polycomb group complexes through microRNAs in cancer, Cancer Cell, 20, 187, 10.1016/j.ccr.2011.06.016 Chase, 2011, Aberrations of EZH2 in cancer, Clin. Cancer Res., 17, 2613, 10.1158/1078-0432.CCR-10-2156 Cheng, 2011, EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis, Cancer Res., 71, 4028, 10.1158/0008-5472.CAN-10-3342 Chesi, 1998, The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts, Blood, 92, 3025, 10.1182/blood.V92.9.3025 Crea, 2012, Polycomb genes and cancer: time for clinical application?, Crit. Rev. Oncol. Hematol., 83, 184, 10.1016/j.critrevonc.2011.10.007 Creasy, C.L., McCabe, M.T., Korenchuk, S., Diaz, E., Ott, H., Thompson, C.S., Ganji, G., Gorman, S.A., LaFrance, L.V., Brandt, M., et al. (2012). A novel selective EZH2 inhibitor exhibits anti-tumor activity in lymphoma with EZH2 activating mutations Paper presented at: American Association for Cancer Research Annual Conference (Chicago, AACR). Ernst, 2010, Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders, Nat. Genet., 42, 722, 10.1038/ng.621 Friedman, 2009, The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2, Cancer Res., 69, 2623, 10.1158/0008-5472.CAN-08-3114 Gong, 2011, Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome, Cancer, 117, 5476, 10.1002/cncr.26179 Herrera-Merchan, 2012, Ectopic expression of the histone methyltransferase Ezh2 in haematopoietic stem cells causes myeloproliferative disease, Nat. Commun., 3, 623, 10.1038/ncomms1623 Hudlebusch, 2011, The histone methyltransferase and putative oncoprotein MMSET is overexpressed in a large variety of human tumors, Clin. Cancer Res., 17, 2919, 10.1158/1078-0432.CCR-10-1302 Jaju, 2001, A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood acute myeloid leukemia, Blood, 98, 1264, 10.1182/blood.V98.4.1264 Jiao, 2011, DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors, Science, 331, 1199, 10.1126/science.1200609 Jones, 2007, The epigenomics of cancer, Cell, 128, 683, 10.1016/j.cell.2007.01.029 Kassambara, 2009, MMSET is overexpressed in cancers: link with tumor aggressiveness, Biochem. Biophys. Res. Commun., 379, 840, 10.1016/j.bbrc.2008.12.093 Kleer, 2003, EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells, Proc. Natl. Acad. Sci. USA, 100, 11606, 10.1073/pnas.1933744100 Kondo, 2008, Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation, Nat. Genet., 40, 741, 10.1038/ng.159 Kotake, 2007, pRB family proteins are required for H3K27 trimethylation and Polycomb repression complexes binding to and silencing p16INK4alpha tumor suppressor gene, Genes Dev., 21, 49, 10.1101/gad.1499407 Krivtsov, 2007, MLL translocations, histone modifications and leukaemia stem-cell development, Nat. Rev. Cancer, 7, 823, 10.1038/nrc2253 Kuo, 2011, NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming, Mol. Cell, 44, 609, 10.1016/j.molcel.2011.08.042 Lauring, 2008, The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity, Blood, 111, 856, 10.1182/blood-2007-05-088674 Lawson, 2007, Isolation and functional characterization of murine prostate stem cells, Proc. Natl. Acad. Sci. USA, 104, 181, 10.1073/pnas.0609684104 Li, 2009, The target of the NSD family of histone lysine methyltransferases depends on the nature of the substrate, J. Biol. Chem., 284, 34283, 10.1074/jbc.M109.034462 Lu, 2010, Regulation of tumor angiogenesis by EZH2, Cancer Cell, 18, 185, 10.1016/j.ccr.2010.06.016 Margueron, 2011, The Polycomb complex PRC2 and its mark in life, Nature, 469, 343, 10.1038/nature09784 Martinez-Garcia, 2011, The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells, Blood, 117, 211, 10.1182/blood-2010-07-298349 Min, 2010, An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaB, Nat. Med., 16, 286, 10.1038/nm.2100 Morin, 2010, Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin, Nat. Genet., 42, 181, 10.1038/ng.518 Nguyen, 2011, The diverse functions of Dot1 and H3K79 methylation, Genes Dev., 25, 1345, 10.1101/gad.2057811 Nikoloski, 2010, Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes, Nat. Genet., 42, 665, 10.1038/ng.620 Ram, 2011, Combinatorial patterning of chromatin regulators uncovered by genome-wide location analysis in human cells, Cell, 147, 1628, 10.1016/j.cell.2011.09.057 Richter, 2009, EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation, Proc. Natl. Acad. Sci. USA, 106, 5324, 10.1073/pnas.0810759106 Sander, 2008, MYC stimulates EZH2 expression by repression of its negative regulator miR-26a, Blood, 112, 4202, 10.1182/blood-2008-03-147645 Santra, 2003, A subset of multiple myeloma harboring the t(4;14)(p16;q32) translocation lacks FGFR3 expression but maintains an IGH/MMSET fusion transcript, Blood, 101, 2374, 10.1182/blood-2002-09-2801 Seligson, 2005, Global histone modification patterns predict risk of prostate cancer recurrence, Nature, 435, 1262, 10.1038/nature03672 Spannhoff, 2009, Cancer treatment of the future: inhibitors of histone methyltransferases, Int. J. Biochem. Cell Biol., 41, 4, 10.1016/j.biocel.2008.07.024 Stec, 1998, WHSC1, a 90 kb SET domain-containing gene, expressed in early development and homologous to a Drosophila dysmorphy gene maps in the Wolf-Hirschhorn syndrome critical region and is fused to IgH in t(4;14) multiple myeloma, Hum. Mol. Genet., 7, 1071, 10.1093/hmg/7.7.1071 Takeshita, 2005, Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo, Proc. Natl. Acad. Sci. USA, 102, 12177, 10.1073/pnas.0501753102 Tan, 2007, Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells, Genes Dev., 21, 1050, 10.1101/gad.1524107 Varambally, 2002, The polycomb group protein EZH2 is involved in progression of prostate cancer, Nature, 419, 624, 10.1038/nature01075 Varambally, 2008, Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer, Science, 322, 1695, 10.1126/science.1165395 Varela, 2011, Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma, Nature, 469, 539, 10.1038/nature09639 Wagner, 2012, Understanding the language of Lys36 methylation at histone H3, Nat. Rev. Mol. Cell Biol., 13, 115, 10.1038/nrm3274 Yamada, 2011, Aberrant expression of EZH2 is associated with a poor outcome and P53 alteration in squamous cell carcinoma of the esophagus, Int. J. Oncol., 38, 345 Yamagishi, 2012, Polycomb-mediated loss of miR-31 activates NIK-dependent NF-κB pathway in adult T cell leukemia and other cancers, Cancer Cell, 21, 121, 10.1016/j.ccr.2011.12.015 Yu, 2007, Integrative genomics analysis reveals silencing of beta-adrenergic signaling by polycomb in prostate cancer, Cancer Cell, 12, 419, 10.1016/j.ccr.2007.10.016 Zhang, 2012, The genetic basis of early T-cell precursor acute lymphoblastic leukaemia, Nature, 481, 157, 10.1038/nature10725